¼¿ï´ëÇб³º´¿ø 2022 SNUH Precision Medicine Symposium : 2022-12-02±³À°ÀÏÀÚ : 2022-12-02
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦
±³À°ÁÖÁ¦ :
2022 SNUH Precision Medicine SymposiumÁÖÃÖ±â°ü : ¼¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¤¹ÐÀÇ·á¼¾ÅÍ
´ã´çÀÚ : À忹Àº
¿¬¶ôó : 02-2072-4533
À̸ÞÀÏ :
02916@snuh.org ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ¾È°ú, À̺ñÀÎÈÄ°ú, ºñ´¢ÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú±âŸ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 13:00~13:10 °³È¸»ç ±èŹÎ(¼¿ï´ëÇб³º´¿ø Á¤¹ÐÀÇ·á¼¾ÅÍÀå)
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 13:10~13:35 ¼¿ï´ëº´¿ø Àü¾ÏÆгΰú ÁúȯƯÀÌÆгΠÇöȲ°ú ÀÀ¿ë ÀüÀ±°æ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 13:35~14:00 ºñ´¢¾Ï¿¡¼ First Cancer Panels Âü¿© ¹× ÀÓ»ó °æÇè Á¤Ã¢¿í(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 14:00~14:25 NGS-based circulating-tumor DNA (ctDNA) analysis ÀÌÁö¼ö(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 14:25~14:50 Clinical Bioinformatics: Challenges and Key Considerations À±È«¼®(¼¿ï´ëÇб³º´¿ø)
ÈÞ½Ä 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 14:50~15:10 ÈÞ½Ä ()
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 15:10~15:50 µ¥ÀÌÅͱâ¹Ý ÃÊ°³ÀÎÈ ¸ð¹ÙÀÏ °Ç°°ü¸® ¼ºñ½º ȲÈñ(Ä«Ä«¿ÀÇコÄɾî)
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 15:50~16:20 Telomere maintenance mechanisms in gliomas ¹Úö±â(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 16:20~16:50 ±Ø¹Ì·® ctDNA °ËÃâÀ» ÅëÇÑ Á¾¾ç Áø´Ü°ú ¾Ï Àç¹ß ½ºÅ©¸®´× ¹æµÎÈñ(¿¬¼¼´ëÇб³)
±³À°½Ã°£ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 16:50~17:20 Pan-cancer single cell analysis of myeloid cells ¹Ú¿õ¾ç(»ï¼º¼¿ïº´¿ø À¯Àüü¿¬±¸¼Ò)
Åä·Ð 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 17:20~17:30 QA ()
±âŸ 12-02 ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦ 17:30~17:40 Æóȸ ()